rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2004-3-24
|
pubmed:abstractText |
The Src homology domain 2 (SH2)-containing tyrosine phosphatase SHP-2 has been implicated in the regulation of the phosphatidylinositol 3'-kinase (PI3K)/Akt pathway. The ability of SHP-2 to regulate the PI3K/Akt pathway is suggested to result in the positive effect of SHP-2 on cell survival. Whether SHP-2 regulates insulin-like growth factor-1 (IGF-1)-dependent activation of Akt at the level of PI3K has yet to be established. Furthermore, the identification of the down-stream apoptotic target engaged by SHP-2 in cell survival also has yet to be determined. Here, we show that overexpression of a catalytically inactive mutant of SHP-2 inhibited insulin-like growth factor-1 (IGF-1)-dependent PI3K and Akt activation. Consistent with the observation that SHP-2 participates in pro-survival signaling fibroblasts expressing a deletion within exon 3 of SHP-2, which results in a truncation of the amino-terminus SH2 domain (SHP-2(Ex3-/-)), were hypersensitive to etoposide-induced cell death. SHP-2(Ex3-/-) fibroblasts exhibited enhanced levels of etoposide-induced caspase 3 activity as compared to wild-type fibroblasts and the enhanced level of caspase 3 activity was suppressed by a caspase 3-specific inhibitor. Re-introduction of wild-type SHP-2 into the SHP-2(Ex3-/-) fibroblasts rescued the hypersensitivity to etoposide-induced caspase 3 activation. The effects of abrogating SHP-2 function on cell survival were not specific to the loss of the amino-terminus SH2 domain of SHP-2 since RNAi-mediated knock-down of SHP-2 also reduced cell survival. Taken together, these data indicate that the catalytic activity of SHP-2 is required to regulate the PI3K/Akt pathway and thus likely participates in anti-apoptotic signaling by suppressing caspase 3-mediated apoptosis.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Casp3 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Caspases,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Intracellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/Nucleic Acid Synthesis Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Tyrosine Phosphatase...,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Tyrosine Phosphatases,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt,
http://linkedlifedata.com/resource/pubmed/chemical/Ptpn11 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/SH2 Domain-Containing Protein...,
http://linkedlifedata.com/resource/pubmed/chemical/Somatomedins
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0021-9541
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
199
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
227-36
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15040005-Animals,
pubmed-meshheading:15040005-Apoptosis,
pubmed-meshheading:15040005-Caspase 3,
pubmed-meshheading:15040005-Caspases,
pubmed-meshheading:15040005-Cells, Cultured,
pubmed-meshheading:15040005-Enzyme Activation,
pubmed-meshheading:15040005-Etoposide,
pubmed-meshheading:15040005-Fibroblasts,
pubmed-meshheading:15040005-Immunoblotting,
pubmed-meshheading:15040005-Intracellular Signaling Peptides and Proteins,
pubmed-meshheading:15040005-Mice,
pubmed-meshheading:15040005-Nucleic Acid Synthesis Inhibitors,
pubmed-meshheading:15040005-Phosphatidylinositol 3-Kinases,
pubmed-meshheading:15040005-Precipitin Tests,
pubmed-meshheading:15040005-Protein Tyrosine Phosphatase, Non-Receptor Type 11,
pubmed-meshheading:15040005-Protein Tyrosine Phosphatases,
pubmed-meshheading:15040005-Protein-Serine-Threonine Kinases,
pubmed-meshheading:15040005-Proto-Oncogene Proteins,
pubmed-meshheading:15040005-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:15040005-SH2 Domain-Containing Protein Tyrosine Phosphatases,
pubmed-meshheading:15040005-Signal Transduction,
pubmed-meshheading:15040005-Somatomedins,
pubmed-meshheading:15040005-Transfection,
pubmed-meshheading:15040005-src Homology Domains
|
pubmed:year |
2004
|
pubmed:articleTitle |
SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis.
|
pubmed:affiliation |
Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520-8066, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|